Smart for Life (SMFL) Teams up With Diamond Creek Capital

IPO Buyers Liked it at $5.00. We Liked it at $0.85. We Love it at $0.55. LIVE...

Video Interview: Smart for Life (SMFL) CEO A.J. Cervantes.

Excellent interview. We were at the Noble Investor Conference to see it live. And we were at the manufacturing plant this Friday....

Smart For Life to Present at The Noble Capital Markets Eighteenth Annual Investor Conference.

MIAMI, April 14, 2022 (GLOBE NEWSWIRE) -- Smart for Life, Inc. (Nasdaq: SMFL) (“Smart for Life” or the “Company”), a global leading...

Adding Smart for Life (SMFL) $0.85 to the Watch List.

Adding another "Broken" IPO to the Watch List. We're not sure if "broken" is the appropriate description, when...
VYRE Network

VYRE Network (CAPV) Now Integrated With Samsung TV

Las Vegas, Nevada--(Newsfile Corp. - December 10, 2021) - VYRE Network (OTC Pink: CAPV) (a wholly-owned Cabo Verde Capital company, "VYRE") is pleased to announce that...

Billion Dollar Aggregators Buying Mom-and-Pop Amazon Sellers. Simply Amazing.

At least 77 Amazon aggregators have raised roughly $10 billion in total since April 2020, according to Marketplace Pulse.
omniq

OMNIQ (OMQS) Graduates to NASDAQ. And Three Wall Street Research Reports Follow.

Wall Street Brokerage Price Target Estimates of $15 - $18 Per Share. Without disrupting legacy sales - CEO Shai...

Hapbee (HAPB) Adds 18 New Signal Blends in Major Expansion of Its Digital Wellness...

Hapbee now comes bundled with "lifetime blends" and offers an all-access subscription option. VANCOUVER, BC, Sept. 20, 2021 /PRNewswire/ - Hapbee Technologies,...

OMNIQ (OMQS) to Begin Trading on NASDAQ

100% Here, 100% There, Pretty Soon it all Adds up. Our Sixth Client to Graduate to NASDAQ. Yes, some...

With Hapbee (HAPBF) Who Needs, Drugs, Caffeine or Nicotine?

Record 1 Million Hours of Mood Stimulation Served by Hapbee (HAPBF). TRADING AT THE LOWER END OF...

Latest article

Citius Pharmaceuticals, Inc. (CTXR) Reports Fiscal Full Year 2023 Financial Results and Provides Business...

Mino-Lok® Pivotal Phase 3 trial enrollment completed; topline data expected 2Q 2024 LYMPHIR™ BLA resubmission on track for early 2024

Experts From Harvard, Scripps Research Institute, the University Hospital Zürich, and the Former Chief...

Tharimmune Announces Scientific Advisory Board to Drive Clinical-Stage Lead in Chronic Liver Disease and Early-Stage Tunable Knob Domains for Generating Antibody...

Major Mpox Outbreak in the Democratic Republic of Congo.

As Reported in NPR's Gates and Soda Major Mpox Outbreak in the Democratic Republic of Congo is a...